Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Xilio Therapeutics (XLO) stocks in Canada
Learn how to easily invest in Xilio Therapeutics stocks.
Xilio Therapeutics is a biotechnology business based in the US. Xilio Therapeutics stocks (XLO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $15.9 – a decrease of 9.37% over the previous week. Xilio Therapeutics employs 69 staff and has a market cap (total outstanding stock value) of $422.2 million.
How to buy shares in Xilio Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XLO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Xilio Therapeutics stock price (NASDAQ:XLO)Use our graph to track the performance of XLO stocks over time.
Xilio Therapeutics shares at a glance
|Latest market close||$13.93|
|52-week range||$8.52 - $27.95|
|50-day moving average||$15.97|
|200-day moving average||$16.55|
|Wall St. target price||$34.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-107.16|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Xilio Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Xilio Therapeutics price performance over time
|1 week (2022-01-20)||-9.37%|
|1 month (2021-12-27)||-12.22%|
|3 months (2021-10-27)||-13.42%|
|6 months (2021-07-23)||N/A|
|1 year (2021-01-23)||N/A|
|2 years (2020-01-23)||N/A|
|3 years (2019-01-23)||N/A|
|5 years (2017-01-23)||N/A|
Xilio Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$422.2 million|
TTM: trailing 12 months
Xilio Therapeutics share dividends
We're not expecting Xilio Therapeutics to pay a dividend over the next 12 months.
Xilio Therapeutics overview
Xilio Therapeutics, Inc. , a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts. .
Stocks similar to Xilio Therapeutics
Xilio Therapeutics in the news
Are Institutions Heavily Invested In Xilio Therapeutics, Inc.'s (NASDAQ:XLO) Shares?
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.Read more…
Review the benefits and risks of investing in these tech-focused ETFs.Read more…
We've rounded up stats on some of the most popular electronic components stocks, along with information on how they compare and how to invest. Read more…
More guides on Finder
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Bitcoin Private (BTCP) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
Ask an Expert
You must be logged in to post a comment.